Hrt Financial »

Sonnet Biotherapeutc Hldng I shares owned by Hrt Financial

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Hrt Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $340k 74k 4.58

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Apple Put
Ishares Tr Russell 2000 Etf (IWM)
Nvidia Corporation Put
Microsoft Corporation (MSFT)
Microsoft Corp Put
Johnson & Johnson (JNJ)
Amphenol Corp Cl A (APH)
Applovin Corp Call
Grab Holdings Class A Ord (GRAB)
Apple Call
Tesla Motors (TSLA)

View all positions for Hrt Financial

Top funds holding Sonnet Biotherapeutc Hldng I

Ikarian Capital
Vanguard Group
Hrt Financial
Geode Capital Management
Boothbay Fund Management
Goldman Sachs Group
Citadel Advisors
Virtu Financial
State Street Corporation
BlackRock
Northern Trust
Two Sigma Investments
Investment House
Jane Street
Jpmorgan Chase & Co

View all funds holding Sonnet Biotherapeutc Hldng I